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We have recently demonstrated  that monocytes and K  lymphocytes can decrease 
the viability of group C  meningococci  (Mgc)  in cooperation with human sera from 
persons  immunized  with  group  C  meningococcal  polysaccharide  (Csss)  (I).  This 
antibody-dependent  ceU-mediated  (ADC)  antibacterial  mechanism  occurs  in  the 
absence of added  complement  (1)  as does antibody-dependent  cellular cytotoxicity 
(ADCC)  by K  lymphocytes and  monocytes against  eucaryotic target  cells  (2).  IgA 
isolated  from  patients  convalescing  from  meningococcal  disease,  by  virtue  of  its 
inability to fix complement, blocks IgG- and IgM-dependent complement-mediated 
killing  of Mgc  (3,  4).  The  experiments  in  this  paper were  designed  to  test  if this 
convalescent  IgA, known  to  be immunologically  free of and  functionally  different 
from IgG and  IgM, could  induce  monocyte-mediated anti-meningococcal  activity. 
The purity and functional integrity of the IgA used is particularly important because 
previous  studies  in  which  the  opsonic  activity  of  IgA  was  tested,  have  yielded 
conflicting results (5-9). 
Materials and Methods 
Bacteria.  Group C, serotype II Mgc (strain  138-I) were stored, cultured, and prepared for 
use as targets in the ADC: antibacterial assay as previously described (1). 
Isolat,on of Serum IgG and IgA.  The immunoglobulins used in this study were isolated  from 
two  pools  of sera.  Each  pool  contained  equal  parts  of seven  sera  obtained  7-13  d  after 
disseminated group C type II meningococcal infection.  IgG and IgA were purified from 3-ml 
aliquots of these pooled convalescent  sera by a continuous in-line  chromatography system as 
previously described  (4)  Briefly, fractions that contained IgG and IgA after gel filtrauon over 
Sephadex G-200 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) were 
put over DEAE-Sephadex ion-exchange columns. Isolated IgG and IgA fractions were then 
further purified of one another using specific immunoadsorbent columns of cyanogen bromide- 
activated Separose 4B  (Pharmacia Fine  Chemicals,  Div.  of Pharmacia,  Inc )  to which  the 
appropriate goat anti-human immunoglobulins had been covalently coupled. Maintenance of 
biologic activity was confirmed by the ability of IgG to induce complement-mediated immune 
lysts of group C Mgc and by the ability of IgA to block this lysis was previously described (4). 
Quantttation of Anti-Group C Memngococcal Antibody.  The radioactive antigen-binding  assay 
described by Brandt et al. (10) was used to determine the amount of  anti-group G meningococcal 
antibody present in each Ig pool used.  1  Csss antigen-binding unit (ABU) was defined as that 
amount of antibody that would brad 1 ng of purified group G menmgococcal polysacchande 
ADC Antzbactenal Assay  The  monocyte population  used  tn  this  study  was  prepared  as 
prevtously  described  (1)  by harvesting  those  peripheral  blood  mononuclear cells  that  had 
adhered  to plastic flasks after overnight  incubation  The assay used,  a  modificauon of the 
bactericidal  assay  reported  by  Steigbigel  et  al.  (11), which  measures  leukocyte-mediated 
interference with bacterial growth (as assessed in colony-forming  units), was previously described 
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in detail (1)  To maintam optimal sensitivity in the assay, 0 02 ml of the bacterial suspension 
(containing 0.4-1.3  X  103 Mgc), 0.02  ml purified IgG or IgA, 0.02  ml RPMI-1640 culture 
media (Grand Island Biological Co., Grand Island, N. Y.), and 0.04 ml of monocytes (containing 
1 ×  104 cells) was added at 4°(3 in that order. The tubes were centrifuged at 2,400 g for 10 min 
before the addition of monocytes and at 250 g after the monocyte addition. 
When testing for antigenic specificity, diluted purified IgG and IgA were preincubated with 
purified group C  or group A  meningococcal polysaccharide for 60 min at  4°C  before the 
addition of bacteria. These antigen-antibody mixtures took the place of untreated antibody in 
assay tubes that either contained (experimental) or lacked (control)  monocytes. 
ADC: antibacterial activity is expressed  by the following antibacterial index (ABI).  ABI = 
100 -  (100) (number of viable bacteria in suspensions  incubated with immunoglobulin plus 
monocytes)/(number of viable bacteria in suspensions  incubated with  immunogiobulin but 
without monocytes for the same time period). 
Results 
Antzgen Spec~ctty of lgA- and IgG-dependent Monocyte-medzated Antzbacterzal Activzty.  In 
the absence of added polysaccharide, IgA and IgG induced antibacterial indices of 57 
+_ 4 and 72 :t: 2, respectively. In the presence of 2.4 #g of Csss, no antibacterial activity 
could  be elicited  by either IgA or IgG. In  the presence of even 9.6 #g of group A 
meningococcal  polysaccharide,  IgA and  IgG induced  ABI  of 61  +  2  and  62  :t:  2, 
respectively.  These  data  demonstrate  that  among human  group  C  meningococcal 
convalescent  sera,  the  IgG  and  IgA  antibodies  that  induce  monocyte-mediated 
antibacterial activity against group C Mgc (like the antibodies that induce neutrophil- 
mediated killing [12])  are directed against the capsular polysaccharide, Csss. In terms 
of antigen specificity, convalescent antibodies are, therefore, similar to the post-Csss 
immunization  antibodies  that  induce  neutrophil  (12),  lymphocyte, or mononuclear 
(13) cell-mediated anti-meningococcal activity. 
Effect of the lgA  Concentratzon on Monocyte-medlated Antzbacterzal Actzvzty.  As shown in 
Fig.  1 A, the magnitude of the antibacterial  index was dependent  upon the amount 
of specific anti-Csss IgA present. The minimal amount of IgA that induced ABI of at 
least  40%  contained  0.6  Csss  ABU.  Because  this  amount  of either  IgG or  IgM  is 
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Fta  1  IgA-dependent monocyte-mediated anubactertal  acttv]ty,  each  bar represents the  mean 
+  SEM of three experiments. (A)  Effect  of the concentration of IgA: the amount of specific anti- 
Csss IgA is represented in terms ofCsss ABU per I00 ktl of test reaction mixture, each test reaction 
contained  1 ×  105  monocytes  (B)  Effect  of the  concentration  of monocytes, each  test  reaction 
contained  I 2  ABU  of IgA  (C)  Effect  of the  length  of the  test  mcubatton  Each  100 p,l  of test 
reactmn contamed  I 2 ABU of IgA and  I ×  105 monoc,~tes 454  LOWELL  ET  AL  BRIEF  DEFINITIVE  REPORT 
ineffective in our system (14), the indices induced by IgA could not have been a result 
of undetected cross-contamination of IgA by IgG or IgM. 
Effect of Monocyte Concentratton of lgA-dependent Antzbactenal Acttvtty.  At least  1 X  10  6 
monocytes/ml were required for optimal IgA-dependent antibacterial activity (Fig. 
1 B)  Whereas  5  ×  105 monocytes/ml also  elicited significant  antibacterial  indices, 
when  the  concentration  of monocytes was  decreased  further,  IgA-dependent  anti- 
meningococcal activity was not reproducibly present (Fig.  1 B). 
Effect of the Length of the Test Incubatwn on IgA-dependent Monocyte-medtated Antzbactenal 
Actwtty  Monoeytes, IgA, and bacteria needed to incubate together at  37°C  for at 
least  15  rain  for significant  antibacterial  activity  to  occur;  optimal  antibacterial 
indices were attained after 30-60 min of test incubation (Fig.  1 C). 
Effect  of Subphyswloglc  Temperatures  on  lgA-dependent  Monocyte-medmted  Anttbactenal 
Actwzty.  In  three experiments, when  the  test  incubauon  was  performed at  22°C, 
instead of at 37°C, average ABI were reduced from 67 ±  4 to 29 ±  3. When the test 
was run at 4°C, no significant activity was evident. 
Discussion 
The ability of IgA to promote opsonophagocytosis has been controversial for many 
years. Quie et  al.  (5),  Wilson  (6), and  Reed  (7)  were unable  to demonstrate  IgA- 
dependent neutrophil-mediated phagocytosis of various bacteria in vitro. With pul- 
monary  alveolar macrophages,  Reynolds  et  al.  (8)  found  that  either  IgA  or  IgG 
derived from local secretions could be opsonic. They concluded, however, that  IgG 
was more efficient than IgA (8). Bisno et al. (9), in contrast, showed that phagocytosis 
of gonococci by peripheral blood leukocytes (which included neutrophils and mono- 
cytes) could be enhanced  by IgA as well  as by IgG and  that  the opsonic titers of 
various  fractions of pooled  prostitute  sera  correlated  more  closely with  their  IgA 
concentrations than with their concentrations of IgG. It may be significant that m the 
studies  in  which  opsonic  activity  was  evident,  the  IgA  used  was  derived  from 
respiratory secretions  (8)  or sera  (9)  after infection  (8,  9),  whereas  when  bacterial 
opsonization was not evident, the IgA used was derived from normal colostrum (5-7). 
Others have generally used  more bacteria  in  cell-dependent assays  (5-9,  11,  12) 
than we have  The relatively low numbers of bacteria we used (0.4-1.3 ×  104/ml) are 
comparable to the bacterial concentrations that were used to correlate the absence of 
antibody-dependent complement-mediated bactericidal activity with susceptibility to 
meningococcal disease  (15). These low concentrations of bacteria are important  in 
increasing an assay's sensitivity to small amounts of purified immunoglobulin. The 
monocyte concentration, however, although reduced compared with other assays (8, 
11),  needed  to  be  at  least  5  ×  105/ml  to  promote  optimal  interaction  between 
monocytes and bacteria (Fig.  1 B). Although these concentrations may seem to some 
unphysiologic, we note that the concentration of monocytes in peripheral blood is ~4 
×  105/ml, whereas the concentration of bacteria in peripheral blood among 90-95% 
of adults suffering from gram-negative sepsis is <102/ml (16). Moreover, our require- 
ment  of this  concentration of effector cells  in  vitro  is  consistent  with  the  data  of 
Alexander et al  (17), who showed that although one neutrophil is known to be able 
to kill many bacteria, when lowering the concentration of bacteria to 104/ml, 5 ×  105 
neutrophils/ml are still needed for minimal activity and 5 ×  10  6 cells/ml are needed 
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In this paper, and in other papers (1,  13,  14), we have compared our system with 
the  ability of either  mononuclear or  polymorphonuclear cells  to  kill  target  cells 
intracellularly by phagocytosis or extracellularly via ADCC. Whereas antibacterial 
activity by monocytes has generally been considered to be an intracellular event (8, 
11), because monocytes can clearly kill nucleated target cells extracellularly via ADCC 
(2), we hesitate to si~eculate  at this time as to whether the activity we have reported 
occurs via an intra- or extracellular mechanism. We believe that visual examination 
is not adequate to answer this question because distinguishing between target bacteria 
that are inside monocytes from those resting on monocytes is fraught with pitfalls. 
The ADC antibacterial system we have described occurs in the absence of added 
complement; it therefore seems reasonable that this mechanism is most physiologically 
relevant to those sites in vivo where IgA and mononuclear cells are naturally present 
and complement is functionally deficient. Secretory surfaces including nasopharyn- 
geal, respiratory, and  intestinal  mucosa fit this description  adequately (8,  18,  19). 
Accordingly, we postulate that one function of specific antibacterial secretory IgA, 
may be to promote the ability of local monocytes and macrophages to limit bacterial 
multiplication among mucosal tissues, thereby decreasing the opportunity for systemic 
invasion by pathogenic bacteria. Indeed, activation of the complement cascade among 
extravascular tissues may result in unwanted concomitant generation of local immu- 
nopathology and inflammation. IgA, then, by virtue of its ability to block comple- 
ment-mediated lysis (3, 4) while facilitating cell-mediated antibacterial activity, may 
be thought of as having an immunoregulatory role. That  IgA does not block IgG- 
dependent monocyte and K lymphocyte-mediated antibacterial activity (14) supports 
this concept. 
Immunization with Csss protects against group C  meningococcal disease (20) and 
induces  antibodies  that  are  antibacterial  in  cooperation  with  complement  (21), 
neutrophils  (12),  monocytes, and K  lymphocytes (1). In addition, Gotschlich et al. 
(22)  have  suggested  that  systemic  Csss  immunization  specifically  increases  local 
defenses as  evidenced  by  the  fact  that  nasopharyngeal carriage  of group  C  Mgc 
among vaccinated persons  is low compared with control  groups.  Because Csss  im- 
munization induces antibodies of all three classes  (21),  we speculate that  the ADC 
antibacterial mechanism we have reported may contribute toward the enhanced local 
immunity described. This mechanism may also have been operative in the experiments 
of Freter, who showed that protection against enteric cholera infection was associated 
with  a  complement-independent  antibacterial  capability  of secretory  IgA,  which 
required  intact  intestinal  cells  (23)  and  was  inhibited  by  the  potent  inhibitor  of 
phagocytosis, iodoacetate (24). 
Appropriate evaluation of the role of this mechanism in local immunity requires 
the use of  secretory immunoglobulins and local mononuclear cells, particularly against 
enteric or respiratory pathogens against which local secretory immunity is thought to 
be  of major  importance  (25).  This  study suggests  that  such  experiments  may  be 
fruitful. Indeed, we have evidence that K  lymphocytes and monocytes can mediate 
ADC antibacterial activity against shigellae (G. H. Lowell, R. P. MacDermott, P. L. 
Summers, A. A. Reeder, M. J. Bertovich, and S. B. Formal. Manuscript in prepara- 
tion.). 
Summary 
IgA purified from the sera of patients convalescing from disseminated group  C 
meningococcal disease induced human monocyte-mediated anti-meningococcal actw- 456  LOWELL  ET  AL  BRIEF DEFINITIVE REPORT 
ity in vitro in the absence of complement. Both IgA- and IgG-dependent activity were 
directed  against  the  group  C  meningococcal  polysaccharide  (Csss)  capsule.  The 
amount  of IgA that  was  effective bound  <  1 ng of Csss.  Antibacterial activity was 
dependent  upon  the length and  the temperature of the test  incubation  and on  the 
concentration  of monocytes.  The  implications of this  mechanism  for  local cell-me- 
diated antibacterial immunity are discussed. 
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